BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32802874)

  • 1. Overexpression of lncRNA SNGH3 Predicts Unfavorable Prognosis and Clinical Outcomes in Human Cancers: Evidence from a Meta-Analysis.
    Jiang Y; Le L
    Biomed Res Int; 2020; 2020():7974034. PubMed ID: 32802874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
    Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
    Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential diagnostic and prognostic value of the long non-coding RNA SNHG3 in human cancers: A systematic review and meta-analysis.
    Wang D; Zou L; Luo J; Zhang C; Feng H; Qin G
    Int J Biol Markers; 2022 Mar; 37(1):3-12. PubMed ID: 35130083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic value of long noncoding RNA SNHG7 in cancers: a meta-analysis and bioinformatics.
    Wang J; Du S; Wang C; Zhu Z; Xie B; Zhang B
    Aging (Albany NY); 2021 Oct; 13(20):23796-23809. PubMed ID: 34714775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
    Zhang T; Cao C; Wu D; Liu L
    Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
    Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y
    Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis.
    Zhang C; Ren X; He J; Wang W; Tu C; Li Z
    Cancer Cell Int; 2019; 19():261. PubMed ID: 31632195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
    Zhang G; Cai J
    J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis.
    Agbana YL; Abi ME; Ni Y; Xiong G; Chen J; Yun F; Yi Z; Zhang Q; Yang Z; Kuang Y; Zhu Y
    BMC Cancer; 2020 Jul; 20(1):682. PubMed ID: 32698787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer.
    Zhu J; Kong F; Xing L; Jin Z; Li Z
    Clin Chim Acta; 2018 Apr; 479():43-47. PubMed ID: 29307668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA activated by TGF-β in human cancers: A meta-analysis.
    Fan YH; Ji CX; Xu B; Fan HY; Cheng ZJ; Zhu XG
    Clin Chim Acta; 2017 May; 468():10-16. PubMed ID: 28163033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and Prognostic Value of Long Noncoding RNA SNHG15 in Human Cancers: a Meta-Analysis and Bioinformatics.
    Ge Y; Yang L; Chen X; Shan H; Su Y; Zhou B; Shao Q
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis.
    Zhang Y; Tian Q; Huang S; Wang Q; Wu H; Dong Q; Chen X
    BMC Cancer; 2022 Jan; 22(1):10. PubMed ID: 34979987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
    Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
    Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of lncRNA SNHG1 is associated with metastasis and poor prognosis in cancers: A meta-analysis.
    Yu J; Yan Y; Hua C; Ming L
    Medicine (Baltimore); 2019 Apr; 98(16):e15196. PubMed ID: 31008944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.